No et al. reported on infrequent mTOR expression (7.1%) in endometrial cancer and did not reveal any correlation between mTOR expression and histological type, grade, stage, myometrial invasion, lymph node metastasis and survival in a large group of 141 patients[48]. The gene discussed is MTOR; the disease is endometrial cancer.